Journal of Medical Virology

Article	Citations
Comparison of the pediatric hospitalizations due to COVID‐19 and H1N1pdm09 virus infections during the pandemic period	714
The potential rationale of COVID‐19 vaccine‐induced myopericarditis	491
Comparative analyses of small molecule and antibody inhibition on glycoprotein‐mediated entry of Měnglà virus with other filoviruses	465
Change in willingness to COVID‐19 vaccination in China: Two online surveys during the pandemic	411
Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries	258
Seroprevalence of neutralizing antibodies against the respiratory syncytial virus in healthy adults in Guangzhou, southern China	246
	218
SARS‐CoV‐2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty® COVID‐19 vaccine: Looking for correlates of protection	205
Effects of baloxavir and oseltamivir antiviral therapy on the transmission of seasonal influenza in China: A mathematical modeling analysis	204
Dynamics of spreading of SARS‐CoV‐2 in a Belgian hemodialysis facility: The importance of the analysis of viral strains	193
Public screening for COVID‐19 in Wuhan, China and beware of the antibody positive in women and tumor patients	178
Prisoners of variants, or free to act as prisoners of swabs? The case of Italy	177
Prolonged fecal shedding of SARS‐CoV‐2 in a young immunocompetent COVID‐19 patient: A case report and literature overview	165
Issue Information	155
	153
Issue Information	132
Melatonin use for SARS‐CoV‐2 infection: Time to diversify the treatment portfolio	129
Variants of concern responsible for SARS‐CoV‐2 vaccine breakthrough infections from India	129
Booster vaccination strategy: Necessity, immunization objectives, immunization strategy, and safety	120
Comparison of demographic and clinical characteristics of hospitalized COVID‐19 patients with severe/critical illness in the first wave versus the second wave	120
Preparation of highly specific monoclonal antibodies against SARS‐CoV‐2 nucleocapsid protein and the preliminary development of antigen detection test strips	111
Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID‐19	110
An exploratory study on the propagation of SARS‐CoV‐2 variants: Omicron is the most predominant variant	109
Highly sensitive and rapid detection of SARS‐CoV‐2 via a portable CRISPR‐Cas13a‐based lateral flow assay	107
Impact of hepatitis B surface antigen positive grafts on liver transplantation in patients with benign and malignant liver disease	106

Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples	100
Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark	95
Advances in laboratory detection methods and technology application of SARS‐CoV‐2	91
Examination of control asymptomatic cohorts reveals heightened anti‐EBV and HHV‐6 A/B dUTPase antibodies in the aging populations	89
Ramsay Hunt syndrome and concurrent varicella‐zoster virus meningitis in Denmark: A nationwide cohort study	89
Exploring the dynamics of the 2022 mpox outbreak in Canada	88
Posttranslational modifications of ACE2 protein: Implications for SARS‐CoV‐2 infection and beyond	87
Cytomegalovirus‐RNA Accurately Identifies Clinically Significant Infection Needing Preemptive Therapy in Liver Transplanted Children: A Proof‐of‐Concept Study	87
Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting	85
Real‐world effectiveness of sotrovimab and remdesivir for early treatment of high‐risk hospitalized COVID‐19 patients: A propensity score adjusted retrospective cohort study	85
Cross‐sectional analysis reveals autoantibody signatures associated with COVID‐19 severity	78
Inhibiting cardiac autophagy suppresses Zika virus replication	78
Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022	78
Impact of nonalcoholic fatty liver disease status change on antiviral efficacy of nucleos(t)ide analogues in HBeAg‐positive chronic hepatitis B	78
Significant neutralizing escapes of Omicron and its sublineages in SARS‐CoV‐2‐infected individuals vaccinated with inactivated vaccines	77
Outcomes of definitive local therapy with intensity‐modulated radiation therapy in elderly patients ≥70 years with HPV‐associated oropharyngeal cancer	76
Cytological features of human papillomavirus‐infected immature squamous metaplastic cells from cervical intraepithelial neoplasia grade 2	75
Association between cytomegalovirus seropositivity and all‐cause mortality: An original cohort study	70
Advanced technologies towards improved HPV diagnostics	69
On coming back, the scaring COVID‐19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS‐CoV2 spreading	67
Azvudine and nirmatrelvir–ritonavir in hospitalized patients with moderate‐to‐severe COVID‐19: Emulation of a randomized target trial	67
Unraveling the Role of Mutations Outside the Basal Promoter and Precore Regions in the HBeAg‐Negative Stage of Chronic Hepatitis B	67
Monkeypox Virus Subverts the Inflammatory Response of Macrophages at the Maternal‐Fetal Interface	66
No signs of “tripledemic” in Finnish children	65
Detection of SARS‐CoV‐2 virus in middle ear effusions and its association with otitis media with effusion	64
Influenza vaccination on SARS‐CoV‐2 infection risk: A subgroup analysis on geographic factor	64
ZNFX1 antisense RNA1 promotes antiviral innate immune responses via modulating ZNFX1 function	64
Novel diarylpyrimidine subtypes as HIV‐1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile	63
Pulmonary infection in patients with severe fever with thrombocytopenia syndrome: A multicentre observational study	63
Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID‐19 booster dose in persons with HIV	62
Corrigendum	61
Repurposing of the antibiotic nitroxoline for the treatment of mpox	61
Diversity of picornaviruses detected in diarrheal samples from children in Belém, Brazilian Amazon (1982–2019)	60
Epidemiological Characteristics of Neuro‐Specific Antibodies Following Viral Infections	59
Cytomegalovirus seropositivity and its correlation with all‐cause mortality among US adults	59
Epidemiological characteristics of norovirus infection in pediatric patients during the COVID‐19 pandemic	59
BK Polyomavirus DNAemia With a High DNA Load Is Associated With De Novo Donor‐Specific HLA Antibodies in Kidney Transplant Recipients	58
Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples	58
Clinical Performance of OncoPredict HPV Screening Assay on Self‐Collected Vaginal and Urine Specimens Within the VALHUDES Framework	58
Circulating rotavirus P[8]‐lineage IV, unlike P[8]‐lineage III, significantly related to nonsecretors status in Iranian children	58
Cell Culture of a Swine Genotype 4 Hepatitis E Virus Strain	58
Association of Remdesivir use with bradycardia: A systematic review and meta‐analysis	57
SARS‐CoV‐2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico	57
COVID‐19 and Oncofertility: No SARS‐CoV‐2 in Semen but Inflammation Seems to Affect Sperm Parameters	57
Efficient recall of SARS‐CoV‐2 variant‐reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters	56
Molecular epidemiology of SARS‐CoV‐2 variants in circulation in the state of Maranhão, Brazil	56
Issue Information	55
Establishment of nucleic acid sensing pathways‐based model in predicting response to immunotherapy and targeted drug in hepatitis virus‐related hepatocellular carcinoma	55
Risks of catching COVID‐19 according to vaccination status of healthcare workers during the SARS‐CoV‐2 Delta variant dominant period and their clinical characteristics	54
Reflections Regarding Validation of New HPV Tests With Reduced HPV Genotypes: Report From an IARC Expert Consultation	54

Zoonotic spillover and extreme weather events drive the global outbreaks of airborne viral emerging infectious diseases	53
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients	53
Serological responses to smallpox A33 antigen and monkeypox A35 antigen in healthy people and people living with HIV‐1 from Guangzhou, China	53
Erratum	52
Comment on “A systematic review and meta‐analysis of herpes zoster occurrence/recurrence after COVID‐19 infection and vaccination”	51
Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1‐S, BBIBP‐CorV, and Gam‐COVID‐Vac in an Argentinean cohort	51
RT‐RPA Assisted CRISPR/Cas12a Based One‐Pot Rapid and Visual Detection of the Pan‐Dengue Virus	51
Rotavirus trends and distribution of genotypes before and during COVID‐19 pandemic era: Bangladesh, 2017–2021	51
Comment on “The risk assessment of uveitis after COVID‐19 diagnosis”	50
Correction to “Fullerene (C60 & C70)‐Meso‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C”	50
SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19	50
Identification of a new polyomavirus in distinct human populations and tissues	50
Better detection of Torque teno virus in children with leukemia by metagenomic sequencing than by quantitative PCR	49
SARS‐CoV‐2 ORF3a inhibits cGAS‐STING‐mediated autophagy flux and antiviral function	49
Serum extracellular vesicle‐derived ASS1 is a promising predictor for the occurrence of HEV‐ALF	49
COVID‐19 vaccinations: The unknowns, challenges, and hopes	48
Impact of Nonpharmaceutical Interventions During the COVID‐19 Pandemic on the Epidemiology and Seasonal Patterns of Acute Respiratory Infections in Children	48
A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity	48
	47
Typing of alpha and beta coronaviruses by DNA barcoding of NSP12 gene	47
Issue Information	47
IFN‐α2b Modulates GATA3 Expression to Inhibit Proliferation and Promote Apoptosis in KSHV‐Infected Cells	47
Short and mid‐term SARS‐CoV‐2 antibody response after inactivated COVID‐19 vaccine in hemodialysis and kidney transplant patients	46
Viral fever of unknown origin during COVID‐19 and dengue outbreaks in Pakistan: Is media spreading panic during pandemic?	46
Assessment of clinical outcomes in renal transplant recipients with COVID‐19	46
Influenza is more severe than our newest enemy (COVID‐19) in hospitalized children: Experience from a tertiary center	46
Can COVID‐19 cause atypical forms of pityriasis rosea refractory to conventional therapies?	45
Issue Information	45
Modulation of Covid‐19 cytokine storm by tocilizumab	45
The effectiveness of inactivated SARS‐CoV‐2 vaccine (CoronaVac) on antibody response in participants aged 65 years and older	44
Corrigendum	44
Rhinovirus persistence during the COVID‐19 pandemic—Impact on pediatric acute wheezing presentations	44
Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS‐CoV‐2 from 946 whole‐exome sequencing data in the Turkish population	44
Performance evaluation of Elecsys SARS‐CoV‐2 Antigen immunoassay for diagnostic of COVID‐19	43
Duration from onset to discharge is longer in COVID‐19 patients with low blood regulatory T‐cell counts	43
Assessment of the cobas® HBV RNA investigational assay in the setting of nucleoside analog therapy cessation	43
Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B	42
Incomplete IgG avidity maturation after seasonal coronavirus infections	42
Near full‐length genome analysis of HEV 4b subtype in pigs showed a similarity up to 99.944% compared to a patient in Guangdong province, China	42
Differential avidity determination of IgG directed towards the receptor‐binding domain (RBD) of SARS‐CoV‐2 wild‐type and its variants in one assay: Rational tool for the assessment of protective immun	42
Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis‐associated interstitial lung disease	41
Comparison of intracellular cytokine staining versus an ELISA‐based assay to assess CMV‐specific cell‐mediated immunity in high‐risk kidney transplant recipients	41
Reconstruction of the historic time course of blood‐borne virus contamination of clotting factor concentrates, 1974–1992	40
Incidences of new hepatitis B infection and anti‐hepatitis B core‐negative occult hepatitis B infection among Japanese blood donors in relation to anti‐hepatitis B surface antigen levels	40
Issue Information	40
Differential diagnosis on measles and rubella discarded cases highlights a sharp increase in parvovirus B19 infections in Milan, Northern Italy, in the first months of 2024	40
Mpox in Northeast Brazil: Spatiotemporal analysis and predictors associated with confirmed diagnosis	39
Modulation of Cell Cycle Kinases by Kaposi's Sarcoma‐Associated Herpesvirus	39
Systematic Reevaluation of Repurposed Drugs Against the Main Protease of SARS‐CoV‐2 via Combined Experiments	39
Issue Information	39
Small molecule RAF265 as an antiviral therapy acts against HSV‐1 by regulating cytoskeleton rearrangement and cellular translation machinery	39
Assessment of antibody kinetics in mpox cases with indigenously developed IgM and IgG ELISA	39
Methodological Considerations in Evaluating Recombinant Zoster Vaccine Effectiveness in COPD Patients	39
Genomic epidemiology of the main SARS‐CoV‐2 variants in Italy between summer 2020 and winter 2021	38
The resurgence of influenza A/H3N2 virus in Australia after the relaxation of COVID‐19 restrictions during the 2022 season	38
Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID‐19: A systematic review and meta‐analysis	38
Phylogenetics and phylogeographic characteristics of coxsackievirus A16 in hand foot and mouth disease and herpangina cases collected in Beijing, China from 2019 to 2021	37
Excess risk for acute myocardial infarction mortality during the COVID‐19 pandemic	37
Associations of Lipid Profiles With the Onset of HEV‐Related Acute Liver Failure: A Multicenter Cohort Study	37
Hypertension is still a moving target in the context of COVID‐19 and post‐acute COVID‐19 syndrome	37
The impact of cerebrospinal fluid viral polymerase chain reaction testing on the management of adults with viral meningitis: A multi‐center retrospective study	37
Two‐ and 3‐year outcomes in convalescent individuals with COVID‐19: A prospective cohort study	36
Consistency in human papillomavirus type detection between self‐collected vaginal specimens and physician‐sampled cervical specimens	36
The signature of SARS‐CoV‐2 evolution reflects selective pressures within human guts	36
Prolonged viral shedding in an immunocompromised Korean patient infected with hMPXV, sub‐lineage B.1.3, with acquired drug resistant mutations during tecovirimat treatment	36
Dynamic m6A profiles reveal the role of YTHDC2‐TLR2 signaling axis in Talaromyces marneffei infection	36
Viral metagenomics unveils MW (Malawi) polyomavirus infection in Brazilian pediatric patients with acute respiratory disease	36
Deciphering head and neck cancer microenvironment: Single‐cell and spatial transcriptomics reveals human papillomavirus‐associated differences	36
Cytoplasmic Shift of Interferon Regulatory Factors Co‐Evolved With Jawed Vertebrate Innate Immunity	35
Clinical performance of a newly developed domestic urine‐based HPV test for cervical cancer screening in China	35
Alcohol‐Induced Dendritic Cells and Their Exosomes Promote T‐Cell Immunity in Hepatitis B Virus Transgenic Mice and Patients With Chronic Hepatitis B	35
Research progress in Fc‐effector functions against SARS‐CoV‐2	35
A common mechanism links Epstein‐Barr virus infections and autoimmune diseases	35
Genome and proteomic analysis of risk factors for fatal outcome in children with severe community‐acquired pneumonia caused by human adenovirus 7	34
Recombinant Zoster Vaccine Reduces All‐Cause Mortality, But Not Major Adverse Cardiovascular Events, in Patients With Immune‐Mediated Inflammatory Diseases Receiving Janus Kinase Inhibitors: A Large‐S	34
Whole Genome Sequencing and Genetic Diversity of Respiratory Viruses Detected in Children With Acute Respiratory Infections: A One‐Year Cross‐Sectional Study in Senegal	34
Patterns of Co‐infection of HPV52 With Other HPV Genotypes and Their Risks of Cervical Precancer and Carcinoma	34
The Emerging Roles of Alternative Splicing in Human Oncovirus Infection	34
Hantaan Virus (HTNV) Human Infection on Jeju Island, South Korea: Unique Phylogeny and Epidemiology of HTNV	34
Resurgence of human metapneumovirus infection and influenza after three seasons of inactivity in the post‐COVID‐19 era in Hokkaido, Japan, 2022–2023	33

Response to the Korea National Committee on Immunization Programs' Letter	33
The human papillomavirus late life cycle and links to keratinocyte differentiation	33
Cocirculation of A(H3N2) and B/Victoria increased morbidity in hospitalized patients in the 2019–2020 A(H1N1)pdm09 predominant influenza season in Israel	33
The potential of PCNA inhibition as a therapeutic strategy in cervical cancer	33
Measles in vulnerable populations: An outbreak in Roma settlements of Loire‐Atlantique, France, 2019	33
Viral Interference and Coinfections: A Perspective From Hospital Surveillance of Respiratory Viruses	33
High pre‐Delta and early‐Omicron SARS‐CoV‐2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo)	33
Omicron‐specific mRNA vaccine induced cross‐protective immunity against ancestral SARS‐CoV‐2 infection with low neutralizing antibodies	33
Issue Information	33
Cover Image, Volume 95, Number 11, November 2023	33
The impact of statin therapy on in‐hospital prognosis and endothelial function of patients at high‐to‐very high cardiovascular risk admitted for COVID‐19	33
Changing spectrum and mortality disparities of etiology of liver cirrhosis in Beijing, China	32
Evaluation of an E6/E7 PCR‐capillary electrophoresis fragment analysis in the genotyping of human papillomavirus in archival FFPE samples of oropharyngeal cancer	32
Simple, sensitive, and visual detection of 12 respiratory pathogens with one‐pot‐RPA‐CRISPR/Cas12a assay	32
Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID‐19 vaccine	32
Infection pattern and immunological characteristics of Epstein‐Barr virus latent infection in cervical squamous cell carcinoma	32
Enhanced recombination among Omicron subvariants of SARS‐CoV‐2 contributes to viral immune escape	32
In the age of Omicron variant: Paxlovid raises new hopes of COVID‐19 recovery	32
Association between influenza vaccination and one‐year all‐cause and cardiovascular mortality risk: A self‐controlled case series and matched case‐control study	32
The global disease burden of varicella‐zoster virus infection from 1990 to 2019	32
Epidemiological characteristics and cerebrospinal fluid cytokine profiles of enterovirus encephalitis in children in Hangzhou, China	31
Safety of Low‐Dose Ibuprofen in Non‐Severe Dengue Patients for Managing Fever Is Consistent With Acetaminophen: A Retrospective Observational Study	31
Analysis of mitochondrial DNA cytochrome‐b (CYB) and ATPase‐6 gene mutations in COVID‐19 patients	31
Long COVID syndrome‐associated brain fog	31
T cell epitopes are largely conserved in the SARS‐CoV‐2 Omicron subvariant (BA.1, BA.2, BA.3, and GKA)	31
Detection of Polish cases of highly virulent subtype B of HIV‐1 originating in the Netherlands	31
In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT‐qPCR assays for SARS‐CoV‐2 detection using whole genome sequencing	31
Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan	31
Statistical analysis of the Hungarian COVID‐19 victims	30
Sequential dynamics of virological and serological changes in the serum of SARS‐CoV‐2 infected patients	30
Vaccine development and technology for SARS‐CoV‐2: Current insight	30
Clinical presentations of adult and pediatric SARS‐CoV‐2‐positive cases in a community cohort, Nashville, Tennessee	30
Molecular evolution and genomic characteristics of genotype H1 of measles virus	30
Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID‐19	29
The impact of the COVID‐19 pandemic on the global burden of influenza	29
SARS‐CoV‐2 pseudovirus infectivity and expression of viral entry‐related factors ACE2, TMPRSS2, Kim‐1, and NRP‐1 in human cells from the respiratory, urinary, digestive, reproductive, and immune syste	29
Omicron variant of SARS‐CoV‐2: A pandemic of global concern warrants a cautious approach	29
SARS‐CoV‐2‐Induced PAPOLG Contributes to Inflammation Response by Stabilizing NF‐κB mRNA	29
Current evidence on efficacy of COVID‐19 booster dose vaccination against the Omicron variant: A systematic review	29
Vaccines for Covid‐19: An insight on their effectiveness and adverse effects	29
Reverse genetics systems for SARS‐CoV‐2	29
Diagnostic Performance of a Combined Rapid Antigen Test for Detecting SARS‐CoV‐2, Influenza Virus, and Respiratory Syncytial Virus in Symptomatic Patients in Tertiary Care	29
Red blood cell distribution width: A severity indicator in patients with COVID‐19	29
Obstructive Sleep Apnea and Risk of Respiratory Syncytial Viral Infection: A Retrospective Multi‐Institution Cohort Study	28
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients	28
A case of human buffalopox in Malappuram, India: The role of mpox surveillance in 2022	28
Transferrin Saturation Can Serve as a Novel Biomarker for Predicting the Occurrence and Development of BK Virus‐Related Nephropathy After Kidney Transplantation	28
The impact of cycling hypoxia on the phenotype of HPV‐positive cervical cancer cells	28
Comparison of the immunogenicity of nasal‐spray rVSV vector, adenovirus vector, and inactivated COVID‐19‐based vaccines in rodent models	28
Surveillance for SARS‐CoV‐2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaks	28
A study on the morbid histopathological changes in COVID‐19 patients with or without comorbidities using minimally invasive tissue sampling	28
Erratum	28
Issue Information	27
Overview of autoantibodies in COVID‐19 convalescents	27
The burden of infectious diseases throughout and after the COVID‐19 pandemic (2020–2023) and Russo‐Ukrainian war migration	27
A systematic review and meta‐analysis of herpes zoster occurrence/recurrence after COVID‐19 infection and vaccination	27
Regaining virological suppression in a woman living with a six‐class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests	27
HBV PreC interacts with SUV39H1 to induce viral replication by blocking the proteasomal degradation of viral polymerase	27
Nanomedicine‐mediated recovery of antioxidant glutathione peroxidase activity after oxidative‐stress cellular damage: Insights for neurological long COVID	27
Sequencing of monkeypox virus from infected patients reveals viral genomes with APOBEC3‐like editing, gene inactivation, and bacterial agents of skin superinfection	27
Issue Information	27
Pan‐microscopic examination of monkeypox virus in trophoblasts cells reveals new insights into virions release through filopodia‐like projections	27
Evaluation of host cellular responses to Epstein–Barr virus (EBV) in adult lung transplant patients with EBV‐associated diseases	27
Impact of heavy metals exposure on herpes simplex virus type I infection: A population‐based cross‐sectional study	26
Changes in cerebrospinal fluid proteome of patients with tick‐borne encephalitis	26
Regarding the article prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome by Hao et al	26
Change from low to out‐of‐season epidemics of influenza in China during the COVID‐19 pandemic: A time series study	26
Risks of cutaneous immune‐related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK	26
Recent history and biology of H5N1 influenza A virus infections of farm animals (poultry, goat, alpacas, dairy cattle, barn cats) and humans in the United States of America	26
Unexpected high incidence of parvovirus B19 nucleic acid detection in German blood donors in the winter/spring season 2023/2024	26
Rapid detection of Ebolavirus using isothermal recombinase‐aided amplification	26
Letter to the editor regarding the study on maternal HPV infection and the risk of congenital malformations	26
Regulation of autophagy by SARS‐CoV‐2: The multifunctional contributions of ORF3a	26
Macrophages can transmit coxsackievirus B4 to pancreatic cells and can impair these cells	26
Viral whole genome sequencing reveals high variations in APOBEC3 editing between HPV risk categories	25
Male and female human papilloma virus infection and assisted reproductive technology outcomes: A comprehensive assessment from prevalence in semen to obstetric outcomes	25
Estimating true prevalence through questionnaire data	25
Risks of monkeypox virus infection in children	25
The interplay between lipid droplets and virus infection	25
Prevalence of Human Polyomaviruses in Oral and Oropharyngeal Squamous Cell Carcinoma From Patients Treated at a Cancer Center in Sao Paulo, Brazil	25
Heterologous Versus Homologous COVID‐19 Boosters: Immune Response Outcomes in Renal Transplant Recipients	25
A novel humanized tri‐receptor transgenic mouse model of HAdV infection and pathogenesis	24
Synergy Effects of HPV E6‐E7 Encoding mRNA and Nucleic Acid Immunostimulators Improve Therapeutic Potential in TC‐1 Graft Tumor	24
Genetic Conservation and Diversity of SARS‐CoV‐2 Envelope Gene Across Variants of Concern	24
Four conserved amino acids on human papillomavirus E6 predict clinical high‐risk types	24
SARS‐CoV‐2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID‐19 due to Omicron BA.1 and BA.2	24
Viral metagenomics enables accurate detection of viral pathogens in amniotic fluid samples from pregnant women with suspicion of congenital infection	24
Response to the Letter to the Editor on “Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS‐CoV‐2 Omicron infection”	24
GII.17[P17] and GII.8[P8] noroviruses showed different RdRp activities associated with their epidemic characteristics	24
Alterations in Cellular Gene Expression Due to Co‐Infection With Kaposi's Sarcoma‐Associated Herpesvirus and SARS‐CoV‐2: Implications for Disease Severity	24
Correction to “Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study”	24
Human Cytomegalovirus Replication Enhanced By Placental MicroRNAs	24
Seroepidemiology study of rubella virus antibodies among neonates and pregnant women at hospitals in Henan province, China	23
The pathophysiological and immunological background of the monkeypox virus infection: An update	23
Early recognition of a superinfection: This is the problem in the critically ill COVID‐19 patients	23